This enhanced MHC-dependent allogeneic response may also be responsible for the persistence of donor T cells after treatment with AMV564 in MOLM13CG-engrafted mice, and for the lack of tumor progression coupled with rapid expansion of donor T cells in mice after tumor rechallenge. The gene discussed is HLA-C; the disease is neoplasm.